Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-07-19
1990-04-24
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540145, A61K 3140, C07D43722
Patent
active
049201433
ABSTRACT:
A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.
REFERENCES:
patent: 2951800 (1960-09-01), Sharp
patent: 4649151 (1987-03-01), Dougherty et al.
patent: 4675338 (1987-06-01), Bommer et al.
Morgan et al., Chemical Abstracts, vol. 102, (1985), 61981s.
Pangka et al. Chemical Abstracts, vol. 104, (1986), 207015v.
Richter et al., Chemical Abstracts, vol 108, (1988), 146293t.
Diamond et al., Lancet, (1972), 2:1175-1177.
Dougherty et al., Cancer Res., (1978), 38:2628-2635.
Dougherty et al., "The Science of Photo Medicine", (1982), Regan & Parish editors, pp. 625-638.
Dougherty et al., "Cancer: Principles and Practices of Oncology", (1982), DeVita et al., editor, pp. 1836-1844, (A copy is currently not available).
Dougherty et al., "Porphyrin Localization and Treatment of Tumors", (1984), pp. 301-314.
Dougherty et al., CRC Critical Rev. in Oncology/Hematology, (1984) 2:83-116.
Gregorie et al., Ann. Surg., (1968), 167:827-829.
Dougherty et al., "Porphyrin Photosensitization," Kessel et al., editors, (1983), Plenum Press, pp. 3-12.
Mew et al., J. Immunol., (1983), 130:1473-1477.
Mew et al., Cancer Res., (1985), 45:4380-4386.
Weishaupt et al., Cancer Res., (1976), 36:2326-2329.
Morgan et al., (1984), J. Chem. Soc. Chem. Commun., pp. 1047-1948.
Richter et al., (1987), JNCI 79(6):1327-1331.
Pangka et al., (1986), J. Organic Chem. 51:1094-1100.
Chow Jack K.
Dolphin David
Levy Julia G.
Sternberg Ethan
Raymond Richard L.
University of British Columbia
LandOfFree
Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-35050